非选择队列中保留Retzius间隙机器人辅助根治性前列腺切除术的手术切缘阳性率
本研究在未选择的真实世界队列中报告了保留Retzius间隙机器人辅助根治性前列腺切除术(RS-RARP)的手术切缘阳性率。529例连续患者中,pT2期切缘阳性率为13.3%,pT3期为28.9%,临床显著切缘阳性(>3 mm或多发)占8.1%。结论认为RS-RARP的切缘阳性率可接受,pT3期高于pT2期。
要点
- RS-RARP总体切缘阳性率可接受,pT2为13.3%、pT3为28.9%。
- 临床显著切缘阳性(>3 mm或多发)占8.1%,多见于pT3期。
- 即刻控尿率(无垫或每日1块安全垫)为65%。
核心结论
- RS-RARP的切缘阳性率可接受,pT3期高于pT2期。
研究设计与样本
- 研究在ERUS认证的 fellowship 培训泌尿外科部门进行,经医院批准审计。
主要发现
- 中位年龄64岁,超过97%患者为中危或高危疾病。
- 病理分期T2占66.5%,T3占33.5%。
- pT2患者切缘阳性率为13.3%,pT3患者为28.9%。
- 临床显著切缘阳性(>3 mm或多发)43例(8.1%),其中27例为pT3期。
- 切缘阳性位于尖部占2.6%,前表面和膀胱颈各占0.7%。
关键数值与推荐
- 临床显著切缘阳性定义为切缘长度>3 mm或多发切缘阳性。
临床怎么用
- RS-RARP可用于中高危前列腺癌患者,需关注pT3期切缘阳性风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our aim was to report the positive surgical margin (PSM) rate of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) in an unselected, real-life cohort of patients treated at a fellowship-training urological department. MATERIALS AND METHODS: Demographic, clinical and pathological data of 529 consecutive patients who underwent RS-RARP between January 2017 and December 2020 were collected prospectively and analyzed retrospectively in a hospital-approved audit in a European Association of Urology Robotic Urology Section (ERUS)-approved fellowship program. Overall PSM rates were reported for the entire cohort and for pT2 and pT3 patients separately. We defined clinically significant PSM as any length of >3 mm or multiple PSMs regardless of length. RESULTS: Median patient age was 64 years. More than 97% of the patients had intermediate or high-risk disease. The pathological stages were T2 (66.5%) and T3 (33.5%). Overall PSM was reported in 13.3% of pT2 patients and 28.9% of pT3 patients. Clinically significant PSM was reported in 43 patients (8.1%), and most of them (27 patients) had pT3 disease. Only 2.6% positive margins were reported at the apex and 0.7% on the anterior surface and bladder neck. Immediate continence (defined as no pads or 1 safety pad a day) rate was 65%. CONCLUSIONS: PSM rates of RS-RARP are acceptable and are higher in pT3 disease compared to pT2.
引用
- Bahouth Z, Laniado M, Fowler R, et al. Positive Surgical Margins Rate of Retzius-Sparing Robot-Assisted Radical Prostatectomy in a Contemporary, Unselected Cohort. J Urol. 2021. PMID: 34694141. doi:10.1097/JU.0000000000002295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。